Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Latest filing published 20 Aug 2026 for NEKTAR THERAPEUTICS, €26k. Read the official filing
Filing timeline
BuySaleHoward W. Robin
Insider track record
Disclosed buys
0
Disclosed sells
23
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Howard W. Robin: trading record in brief
Howard W. Robin, listed as chief executive, appears in our data through filings on Nektar Therapeutics shares, published by SEC (Form 4). In total, 32 filings cover trades dated from 19 January 2016 to 18 August 2026.
Every open-market trade on record is a sale: 23 sales worth €1.1M. The totals exclude 2 filings filed without an amount. The rest of the record consists of 7 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
On 20 August 2026 came the latest disclosure, an open-market sale for €26k in Nektar Therapeutics. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Howard W. Robin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
418 shares@ US$71.98Common StockSEC:0001193125-26-359586:0
423 shares@ US$73.002.9% of flowCommon StockSEC:0001193125-26-061885:0
21,667 shares0Common StockSEC:0001193125-25-331187:0
7,110 shares0Common StockSEC:0001193125-25-297850:0
2,100 shares@ US$45.169.1% of flowCommon StockSEC:0000950170-25-114365:0
1,923 shares@ US$32.3741.7% of flowCommon StockSEC:0000950170-25-113691:0
1,500 shares@ US$30.1652.0% of flowCommon StockSEC:0000950170-25-113129:0
1,573 shares@ US$26.59100.0% of flowCommon StockSEC:0000950170-25-110773:0
23,208 shares@ US$0.671.3% of flowCommon StockSEC:0000950170-25-075976:0
23,774 shares@ US$1.012.2% of flowCommon StockSEC:0000950170-25-025035:0
46,995 shares@ US$1.014.2% of flowCommon StockSEC:0000950170-24-138693:0
410,625 shares0Common StockSEC:0000950170-24-137543:0
16,278 shares@ US$1.011.5% of flowCommon StockSEC:0000950170-24-129461:0
14,881 shares@ US$1.281.6% of flowCommon StockSEC:0000950170-24-099352:0
16,650 shares@ US$1.752.5% of flowCommon StockSEC:0000950170-24-062646:0
20,033 shares@ US$0.681.2% of flowCommon StockSEC:0000950170-24-019043:0
19,877 shares@ US$0.490.8% of flowCommon StockSEC:0001209191-23-056182:0
19,998 shares@ US$0.781.4% of flowCommon StockSEC:0001209191-23-046460:0
20,361 shares@ US$0.721.3% of flowCommon StockSEC:0001209191-23-030446:0
19,635 shares@ US$3.005.2% of flowCommon StockSEC:0001209191-23-010952:0
38,014 shares@ US$3.5712.3% of flowCommon StockSEC:0001209191-22-057964:0
410,625 shares0Common StockSEC:0001209191-22-046486:0
68,450 shares0Common StockSEC:0001209191-22-029902:0
12,480 shares@ US$10.956.1% of flowCommon StockSEC:0001209191-22-011438:0
126,050 shares0Common StockSEC:0001209191-21-070692:0
25 of 32 declarations
